Search research articles
Contact Us
Filters
Showing results (11-20 of 34) with videos related to
Page
of 4
Sort By:
American Journal of Nuclear Medicine and Molecular Imaging
|
July 2, 2014
Preclinical evaluation of (111)In-DTPA-INCA-X anti-Ku70/Ku80 monoclonal antibody in prostate cancer
Susan Evans-Axelsson, Oskar Vilhelmsson Timmermand, Charlotte Welinder, et al.
Nuclear Medicine and Biology
|
January 12, 2015
Radiolabeled antibodies in prostate cancer: a case study showing the effect of host immunity on antibody bio-distribution
Oskar Vilhelmsson-Timmermand, Elmer Santos, Daniel L J Thorek, et al.
International Journal of Surgery Protocols
|
June 10, 2024
Research protocol for an observational health data analysis to assess the applicability of randomized controlled trials focusing on newly diagnosed metastatic prostate cancer using real-world data: PIONEER IMI's "big data for better outcomes" program
Giorgio Gandaglia, Francesco Pellegrino, Bertrand De Meulder, et al.
Clinical Genitourinary Cancer
|
October 15, 2022
How Well do Polygenic Risk Scores Identify Men at High Risk for Prostate Cancer? Systematic Review and Meta-Analysis
Aino Siltari, Ragnar Lönnerbro, Karl Pang, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
May 27, 2017
Establishing <sup>177</sup>Lu-PSMA-617 Radioligand Therapy in a Syngeneic Model of Murine Prostate Cancer
Wolfgang P Fendler, Andreea D Stuparu, Susan Evans-Axelsson, et al.
Cancer Biotherapy & Radiopharmaceuticals
|
April 12, 2012
Targeting free prostate-specific antigen for in vivo imaging of prostate cancer using a monoclonal antibody specific for unique epitopes accessible on free prostate-specific antigen alone
Susan Evans-Axelsson, David Ulmert, Anders Örbom, et al.
Nuclear Medicine and Biology
|
May 11, 2018
Microscale radiosynthesis, preclinical imaging and dosimetry study of [<sup>18</sup>F]AMBF<sub>3</sub>-TATE: A potential PET tracer for clinical imaging of somatostatin receptors
Ksenia Lisova, Maxim Sergeev, Susan Evans-Axelsson, et al.
EJNMMI Research
|
October 31, 2018
Preclinical evaluation of PSMA expression in response to androgen receptor blockade for theranostics in prostate cancer
Katharina Lückerath, Liu Wei, Wolfgang P Fendler, et al.
Central European Journal of Urology
|
March 21, 2025
Baseline characteristics and clinical outcomes of prostate cancer patients on delayed palliative management: a PIONEER analysis based on big data
Lana Yh Lai, Vasileios Sakalis, Christos Chatzichristos, et al.
Nature Reviews. Urology
|
April 3, 2023
Unanswered questions in prostate cancer - findings of an international multi-stakeholder consensus by the PIONEER consortium
Muhammad Imran Omar, Steven MacLennan, Maria J Ribal, et al.
Page
of 4
Search research articles
Search
Showing results (11-20 of 34) with videos related to
Sort By:
Page
of 4
American Journal of Nuclear Medicine and Molecular Imaging
|
July 2, 2014
Preclinical evaluation of (111)In-DTPA-INCA-X anti-Ku70/Ku80 monoclonal antibody in prostate cancer
Susan Evans-Axelsson, Oskar Vilhelmsson Timmermand, Charlotte Welinder, et al.
Nuclear Medicine and Biology
|
January 12, 2015
Radiolabeled antibodies in prostate cancer: a case study showing the effect of host immunity on antibody bio-distribution
Oskar Vilhelmsson-Timmermand, Elmer Santos, Daniel L J Thorek, et al.
International Journal of Surgery Protocols
|
June 10, 2024
Research protocol for an observational health data analysis to assess the applicability of randomized controlled trials focusing on newly diagnosed metastatic prostate cancer using real-world data: PIONEER IMI's "big data for better outcomes" program
Giorgio Gandaglia, Francesco Pellegrino, Bertrand De Meulder, et al.
Clinical Genitourinary Cancer
|
October 15, 2022
How Well do Polygenic Risk Scores Identify Men at High Risk for Prostate Cancer? Systematic Review and Meta-Analysis
Aino Siltari, Ragnar Lönnerbro, Karl Pang, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
May 27, 2017
Establishing <sup>177</sup>Lu-PSMA-617 Radioligand Therapy in a Syngeneic Model of Murine Prostate Cancer
Wolfgang P Fendler, Andreea D Stuparu, Susan Evans-Axelsson, et al.
Cancer Biotherapy & Radiopharmaceuticals
|
April 12, 2012
Targeting free prostate-specific antigen for in vivo imaging of prostate cancer using a monoclonal antibody specific for unique epitopes accessible on free prostate-specific antigen alone
Susan Evans-Axelsson, David Ulmert, Anders Örbom, et al.
Nuclear Medicine and Biology
|
May 11, 2018
Microscale radiosynthesis, preclinical imaging and dosimetry study of [<sup>18</sup>F]AMBF<sub>3</sub>-TATE: A potential PET tracer for clinical imaging of somatostatin receptors
Ksenia Lisova, Maxim Sergeev, Susan Evans-Axelsson, et al.
EJNMMI Research
|
October 31, 2018
Preclinical evaluation of PSMA expression in response to androgen receptor blockade for theranostics in prostate cancer
Katharina Lückerath, Liu Wei, Wolfgang P Fendler, et al.
Central European Journal of Urology
|
March 21, 2025
Baseline characteristics and clinical outcomes of prostate cancer patients on delayed palliative management: a PIONEER analysis based on big data
Lana Yh Lai, Vasileios Sakalis, Christos Chatzichristos, et al.
Nature Reviews. Urology
|
April 3, 2023
Unanswered questions in prostate cancer - findings of an international multi-stakeholder consensus by the PIONEER consortium
Muhammad Imran Omar, Steven MacLennan, Maria J Ribal, et al.
Page
of 4